Ku Nam Su, Lee Yongseop, Park Dae Won
Division of Infectious Diseases, Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
Korean J Intern Med. 2025 Sep;40(5):725-733. doi: 10.3904/kjim.2025.037. Epub 2025 Aug 26.
Evidence supporting antibiotic administration within 3 hours in sepsis without shock is limited. Therefore, we conducted a systematic review and meta-analysis to determine whether the timing of antibiotic initiation influences mortality in patients with sepsis or septic shock. We comprehensively searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and the Korean Medical Database from inception to November, 2022, using the keywords "sepsis," "septic shock," "anti-bacterial agents," "time to treatment," and "time factors." Two reviewers independently performed eligibility screening and full-text review. Thirteen studies including 79,246 patients were analyzed: five prospective, seven retrospective, and one retrospective case-control study. In overall sepsis cases, mortality did not differ significantly between patients who received antibiotics within 1 hour and those in the delayed group but was significantly lower in those who received antibiotics within 3 hours than in those in the delayed group. In patients with septic shock, mortality was significantly lower in groups that received antibiotics within both 1 and 3 hours than in the delayed group. In septic shock, administration of antibiotics within 1 hour of diagnosis reduces mortality. In patients with sepsis, antibiotic administration within 3 hours, but not necessarily within 1 hour, was associated with reduced mortality.
支持在无休克的脓毒症患者中3小时内给予抗生素的证据有限。因此,我们进行了一项系统评价和荟萃分析,以确定开始使用抗生素的时间是否会影响脓毒症或脓毒性休克患者的死亡率。我们使用关键词“脓毒症”“脓毒性休克”“抗菌药物”“治疗时间”和“时间因素”,全面检索了从创刊至2022年11月的PubMed、EMBASE、Cochrane对照试验中央登记库和韩国医学数据库。两名 reviewers 独立进行了资格筛选和全文审查。分析了13项研究,包括79246例患者:5项前瞻性研究、7项回顾性研究和1项回顾性病例对照研究。在总体脓毒症病例中,1小时内接受抗生素治疗的患者与延迟组患者的死亡率无显著差异,但3小时内接受抗生素治疗的患者的死亡率显著低于延迟组患者。在脓毒性休克患者中,1小时和3小时内接受抗生素治疗的组的死亡率显著低于延迟组。在脓毒性休克中,诊断后1小时内给予抗生素可降低死亡率。在脓毒症患者中,3小时内而非一定在1小时内给予抗生素与死亡率降低相关。